Rocket Lab's HASTE Is Flying Hypersonic Missions for the Pentagon. Here's the Defense Business Hiding Inside a Space Stock.

Rocket Lab secured a $266M U.S. Space Force contract for up to 18 suborbital missile defense launches and previously signed a $190M, 20-launch Pentagon agreement for hypersonic testing—strengthening its defense revenue base. It also won a $397M Space Force award to design/build/operate advanced Flatellite spacecraft for the SB-AMTI program, while partnerships support missile tracking/interception efforts. The article frames this defense pivot as stabilizing earnings versus cyclical commercial launches, supporting longer-term upside as Rocket Lab progresses with its $8B Iridium acquisition.

Analysis

RKLB is starting to look less like a speculative launch story and more like a scaled government subcontractor with recurring test cadence. The market usually rewards that transition before the income statement fully catches up, because utilization, pricing power, and backlog visibility can expand the multiple even if reported margins stay noisy for a few quarters. The key second-order effect is that each additional defense program increases the value of Rocket Lab’s fixed launch/ground infrastructure, so incremental revenue should be disproportionately profitable once cadence inflects.

The competitive read-through is better for RKLB than for pure-play launch peers because integrated hardware-plus-services vendors are harder to displace in program-of-record procurement. KTOS remains the closest relative in hypersonic testing, but the prize is likely shared, not winner-take-all; that limits upside to any single contract while lowering the risk that awards are purely episodic. RTX benefits indirectly as a systems integrator, but the cleaner beneficiary is still RKLB because it owns more of the stack and can monetize multiple budget lines, not just launch events.

The main risk is that the market overestimates how quickly defense headlines convert into free cash flow. Government programs often create working-capital drag, milestone timing risk, and margin pressure from early-stage execution, so the next 1-3 quarters may disappoint if investors extrapolate backlog too aggressively. The biggest contrarian tell is any large M&A or leverage-funded expansion: that would turn a clean backlog story into a balance-sheet story, which could compress the multiple if integration or financing terms are harsh.

Key Decisions for Investors

• Go long RKLB on 5-10% pullbacks, targeting a 3-6 month horizon; thesis is backlog-to-cash conversion and multiple expansion if defense revenue becomes a larger share of mix. Falsify if next two quarters show contract wins without sequential improvement in gross margin or operating cash flow.
• Use a call spread rather than outright equity for RKLB into the next earnings cycle: buy 6-12 month upside exposure while capping premium risk if the market has already priced in the contract backlog. Best setup is after post-news consolidation, not into immediate strength.
• Pair trade: long RKLB / short VSAT over 6-18 months. The logic is that integrated, sovereign-space platforms should take share from legacy satcom providers with slower product cycles and weaker program control. Cover the short if VSAT wins a new resilient-military communications program or if RKLB’s defense margin guidance deteriorates.
• Watch KTOS as the nearest operating comp and potential sentiment hedge. If KTOS outperforms RKLB despite similar hypersonic exposure, it likely signals investors are preferring lower execution risk and RKLB’s valuation premium is vulnerable.